WORLD INTELLECTUAL PROPERTY ORGANIZATION
International Bureau
PCT
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT)
(51) International Patent Classification * .
A61B 17/32
Al
(11) International Publication Number: WO 97/42888
(43) International Publication Date: 20 November 1997 (20. 1 1 .97)
(21) International Application Number: PCT/US97/08762
(22) Internationa! Filing Date: 16 May 1997 (16.05.97)
(30) Priority Data:
60/017,133
17 May 1996 (17.05.96)
US
60/019,918
14 June 1996(14.06.96)
US
60/023,658
1 August 1996 (01.08.96)
US
60/025,340
3 September 1996 (03.09.96)
US
08/714,548
16 September 1996 (16.09.96)
US
08/710.456
17 September 1996 (17.09.96)
US
08/727,074
8 October 1996 (08.10.96)
us
(71) Applicant (for all designated States except US): MERCURY
DIAGNOSTICS INC. [US/US]; Suite D, 1 137 San Antonio
Road, Palo Alto, CA 94303 (US).
(72) Inventors; and
(75) Inventors/Applicants (for US only): DOUGLAS, Joel, S.
[US/US]; 2048 Calabazas Boulevard, Santa Clara, CA
95051 (US). ROE, Jeffrey, N. [US/US]; 3212 Veracruz
Drive, San Ramon, CA 94583 (US). RADWANSKI,
Ryszard [US/US]; 7003 "G" Rodling Street, San Jose, CA
95138 (US). GRAGE, Henry, M., Jr. [US/US]; 175 Tenby
Terrace, Danville, CA 94506 (US). SANCHEZ, Michael,
S. [US/US]; 682 Rustic Lane, Mountain View, CA 94040
(US). DREXLER, Andrew, M, [US/US]; 12580 La Cresta
Drive, Us Altos Hills. CA 94022 (US). DUCHON, Brent,
G. [US/US]; 410 Milan Drive #106, San Jose, CA 95134
(US).
(74) Agents: DILLAHUNTY, T., Gene et a!.; Bums, Doane,
Swecker A Mathis, L.L.P., P.O. Box 1404, Alexandria, VA
22313-1404 (US).
(81) Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR.
BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FL GB. GE.
GH, HU, 1L, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR,
LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ,
PL, PT, RO, RU, SD, SE, SG. SI, SK, TJ, TM, TR, TT,
UA, UG, US, UZ, VN, YU, ARIPO patent (GH, KE, LS,
MW, SD. SZ, UG), Eurasian patent (AM, A2; BY, KG, KZ,
MD, RU. TJ, TM), European patent (AT, BE, CH, DE, DK.
ES, FI, FR, GB, GR, IE, IT, LU, MC. NL, PT, SE). OAPI
patent (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE,
SN, TD, TG).
Published
With international search report.
Before the expiration of the time limit for amending the
claims and to be republished in the event of the receipt of
amendments.
(54) Title: BLOOD AND INTERSTITIAL FLUID SAMPLING DEVICE
(57) Abstract
A device and method for lancing a patient, virtually simul-
taneously producing and collecting a small fluid sample from a
body. The device comprises a blood collection system including a
lancing needle (16), drive mechanism (11), kneading or vibration
mechanism (25), optional suction system (7), and sample ejection
mechanism. The device is preferably sized to be hand-held in one
hand and operable with one hand. The device can optionally contain
integral testing or analysis component (83) for receiving the sample
and providing testing or analysis indication or readout for the user.
A method involves piercing the skin at a rapid rate, kneading the
surrounding area by ultrasonic action, piezoelectric or mechanical
oscillation, to stimulate the blood flow from the wound, drawing the
fluid using a pumping system.
FOR THE PURPOSES OF INFORMATION ONLY
Codes used to identify States party to the PCT on the front pages of pamphlets publishing international applications under the PCT.
AL
Albania
£5
Spain
LS
Lesotho
SI
Slovenia
AM
Armenia
PI
Finland
LT
Lithuania
SK
Slovakia
AT
Austria
FR
Prance
LU
Luxembourg
SN
Senegal
AU
Australia
CA
Gabon
LV
Latvia
SZ
Swaziland
AZ
Azerbaijan
GB
United Kingdom
MC
Monaco
TO
Chad
BA
Bosnia and Herzegovina
GE
Georgia
MO
Republic of Moldova
TG
Togo
BB
Barbadoc
GH
Ghana
MG
Madagascar
TJ
Ta^kislan
BE
Belgium
GN
Guinea
MK
The former Yugoslav
TM
Turkmenistan
BF
Burkina Rao
GR
Greece
Republic of Macedonia
TR
Turkey
BG
Bulgaria
HU
Hungary
ML
Mali
TT
Trinidad and Tobago
BJ
Benin
IE
Ireland
MN
Mongolia
UA
Ukraine
BR
Brazil
1L
Urael
MR
Mauritania
UG
Uganda
BY
Belarus
IS
Iceland
MW
Malawi
US
United States of America
CA
Canada
IT
Italy
MX
Mexico
UZ
Uzbekistan
CP
Central African Republic
JP
Japan
NE
Niger
VN
Viet Nam
CC
Congo
KK
Kenya
NL
NethcrUndi
YU
Yugoslavia
CH
Switzerland
KG
Kyrgyzstaa
NO
Norway
ZW
Zimbabwe
CI
Cotedlvoire
KP
Democratie People' t
NZ
New Zealand
CM
Cameroon
Republic of Korea
PL
Poland
CN
China
KR
Republic of Korea
PT
Portugal
CU
Cuba
KZ
Kazakttan
RO
Romania
cz
Czech Republic
LC
Saint Lucia
RU
Russian Federation
DK
Germany
U
SD
Sudan
DK
Denmark
LK
Sri Lanka
SE
Sweden
EE
Estonia
LR
Liberia
SG
Singapore
WO 97/42888
PCT/US97/08762
BLOOD AND INTERSTITIAL FLUID SAMPLING DEVICE
Field of the Invention
The present invention relates to devices and methods for obtaining
samples of blood and other fluids from the body for analysis or processing.
5 Background of the Invention
Many medical procedures in use today require a relatively small sample
of blood, in the range of 5 - 50 pL. It is more cost effective and less traumatic
to the patient to obtain such a sample by lancing or piercing the skin at a
selected location, such as the finger, to enable the collection of 1 or 2 drops of
10 blood, than by using a phlebotomist to draw a tube of venous blood. With the
advent of home use tests such as self monitoring of blood glucose, there is a
requirement for a simple procedure which can be performed in any setting by a
person needing to test.
Lancets in conventional use generally have a rigid body and a sterile
15 needle which protrudes from one end. The lancet may be used to pierce the
skin, thereby enabling the collection of a blood sample from the opening
created. The blood is transferred to a test device or collection device. Blood is
most commonly taken from the fingertips, where the supply is generally
excellent. However, the nerve density in this region causes significant pain in
20 many patients. Sampling of alternate site, such as earlobes and limbs, is
sometimes practiced to access sites which are less sensitive. These sites are also
less likely to provide excellent blood samples and make blood transfer directly
to test devices difficult.
Repeated lancing in limited surface areas (such as fingertips) results in
25 callous formation. This leads to increased difficulty in drawing blood and
increased pain.
To reduce the anxiety of piercing the skin and the associated pain, many
spring loaded devices have been developed. The following two patents are
representative of the devices which were developed in the 1980s for use with
30 home diagnostic test products.
WO 97/42888
PCT/US97/08762
U.S. Patent No. 4,503,856, Cornell et al M describes a spring loaded lancet
injector. The reusable device interfaces with a disposable lancet. The lancet
holder may be latched in a retracted position. When the user contacts a release,
a spring causes the lancet to pierce the skin at high speed and then retract. The
5 speed is important to reduce the pain associated with the puncture.
U.S. Patent No. 4,517,978, Levin et ah, describes a blood sampling
instrument. This device, which is also spring loaded, uses a standard disposable
lancet. The design enables easy and accurate positioning against a fingertip so
the impact site can be readily determined. After the lancet pierces the skin, a
10 bounce back spring retracts the lancet to a safe position within the device.
In institutional settings, it is often desirable to collect the sample from
the patient and then introduce the sample to a test device in a controlled fashion.
Some blood glucose monitoring systems, for example, require that the blood
sample be applied to a test device which is in contact with a test instrument. In
15 such situations, bringing the finger of a patient directly to the test device poses
some risk of contamination from blood of a previous patient. With such
systems, particularly in hospital settings, it is common to lance a patient, collect
a sample in a micropipette via capillary action and then deliver the sample from
the pipette to the test device.
20 U.S. Patent No. 4,920,977, Haynes, describes a blood collection assembly
with lancet and microcollection tube. This device incorporates a lancet and
collection container in a single device. The lancing and collecting are two
separate activities, but the device is a convenient single disposable unit for
situations when sample collection prior to use is desirable. Similar devices are
25 disclosed in Sarrine, U.S. PaL No. 4,360,016, and- O'Brien, U.S. Pat. No.
4,9249,879.
U.S. Patent Nos. 4,850,973 and 4,858,607, Jordan et al., disclose a
combination device which may be alternatively used as a syringe-type injection
device and a lancing device with disposable solid needle lancet, depending on
30 configuration.
-2-
WO 97/42888
PCT/US97/08762
U.S. Patent No. 5,318,584, Lange et al, describes a Wood lancet device
for withdrawing blood for diagnostic purposes. This invention uses a
rotary/sliding transmission system to reduce the pain of lancing. The puncture
depth is easily and precisely adjustable by the user.
5 Suzuki et al., U.S. Patent No. 5,368,047, Dombrowski, U.S. Patent No.
4,654,513 and Ishibashi et al., U.S. Patent No. 5,320,607, all describe suction-
type blood samplers. These devices develop suction between the lancing site
and the end of the device when the lancet holding mechanism withdraws after
piercing the skin. A flexible gasket around the end of the device helps seal the
10 end around the puncture site until adequate sample is drawn from the puncture
site or the user pulls back on the device.
U.S. Pat. No. 4,637,403, Garcia et al. and U.S. Pat. No. 5,217,480, Haber
et al, disclose combination lancing and blood collection devices which use a
diaphragm to create a vacuum over the wound site.
15 International Application Publication Number WO 95/10223, Erickson et
al, describes a means of collecting and measuring body fluids. This system uses
a disposable lancing and suction device with a spacer member which compresses
the skin around the lance/needle.
Single use devices have also been developed for single use tests, i.e.
20 home cholesterol testing, and for institutional use to eliminate cross-patient
contamination multi-patient use. Crossman et al, U.S. Pat. No. 4,869,249, and
Swierczek, U.S. Pat. No. 5,402,798, also disclose disposable, single use lancing
devices.
Even with the many improvements which have been made, the pain
25 associated with lancing remains a significant issue for many patients. The need
for blood sampling and the fear of the associated pain is also a major obstacle
for the millions of diagnosed diabetics, who do not adequately monitor their
blood glucose due to the pain involved. Moreover, lancing to obtain a blood
sample for other diagnostic applications is becoming more commonplace, and a
30 less painful, minimally invasive device is needed to enhance those applications
and make those technologies more acceptable.
-3 -
WO 97/42888
PCT/US97/08762
An object of the present invention is to provide a device and a method
for obtaining a sample of bodily fluid through the skin which is virtually pain
free and minimally invasive.
Another object of this invention is to provide a method which can result
5 in a sample of either blood or interstitial fluid, depending on the sample site and
the penetration depth utilized. While there are no commercially available
devices utilizing interstitial fluid (ISF) at this time, there are active efforts to
establish the con-elation of analytes, such as glucose, in ISF compared to whole
blood. If ISF could be readily obtained and correlation is established, ISF may
10 be preferable as a sample since there is no interference of red blood cells or
hematocrit adjustment required.
Another object of this invention is to provide a method which can draw a
small but adjustable sample, i.e. 3 pL for one test device and 8 pL for another
test device, as appropriate.
15 Another object of this invention is to provide a method by which the
drawn sample is collected and may be easily presented to a testing device,
regardless of the location of the sample site on the body. This approach helps
with infection control in that multiple patients are not brought in contact with a
single test instrument; only the sampling device with a disposable patient-
20 contact portion is brought to the test instrument. Alternatively, the disposable
portion of a test device may be physically coupled with the sampler so the
sample can be brought directly into the test device during sampling. The test
device may then be read in a test instrument if appropriate or the testing system
can be integrated into the sampler and the test device can provide direct results
25 displayed for the patient.
It is a further object of the invention is to provide a device for minimally
invasive sampling comprising a reusable sampler and disposable sample
collection.
Summary of the Invention
30 In one aspect, the present invention relates to a device which uses
mechanical motion to pierce the skin, and a mechanical kneading or oscillation
WO 97/42888
PCT/US97/08762
to produce a sample of fluid from the body and may employ a back pressure or
vacuum to collect a small fluid sample into the device. More specifically, the
present invention comprises a reusable sampling device and a disposable
piercing/collecting apparatus. The device may also employ a back pressure,
5 capillary or vacuum to collect a small fluid sample into the piercing/collecting
apparatus that may later be discharged to deliver the collected sample to a test
device or other appropriate vessel. The system may alternately be used to
deliver the sample to an integral disposable test device, without collecting and
separately dispensing the body fluid sample.
10 A method aspect of this invention involves piercing of the skin at a rapid
rate (to minimize pain), with a needle (which minimizes the trauma and
pressure-associated pain response which occurs with a traditional lancet). The
skin is kept taut. during the lancing to allow accurate and repeatable penetration
of the needle into the skin. After piercing the skin, the needle is withdrawn
15 from the wound and the surrounding area kneaded by ultrasonic action,
piezoelectric or mechanical oscillation or squeegee motion to stimulate the blood
flow into and from the wound. Additionally heat, electrical potential or friction
can be used to stimulate additional flow of the body fluid. This fluid or blood
flow can also be stimulated by ultrasonic vibration of the skin surrounding the
20 wound. In an alternate embodiment to stimulate blood flow, the needle remains
in the wound for a period of time, with either slow mechanical vibration or
rotation of the needle, ultrasonic, or piezoelectric oscillation of the needle, to
keep the wound open for blood to pool. After the area has been stimulated and
the blood wells up in the wound, a capillary, syringe or pumping system is used
25 to draw microliter samples from the patient. Suction is applied to the needle or
the suction tube through either peristalsis, convection (application of heat to a
capillary tube) or by the piston of a small microsyringe. The piston is pulled
back into the sampler device with spring action, generating a vacuum in the
barrel of the microsyringe and quickly drawing fluid from the body through the
30 needle or the suction tube into the barrel to normalize the pressure differential.
The piston or suction device then can be reversed to dispense the collected
WO 97/42888
PCT/US97/08762
sample. The system can also use a capillary tube which is used to draw the
sample after it has been collected on the skin surface. The capillary tube can
then dispense the sample to a desired test or analysis device by applying
pressure through the tube or simply contacting the end of the tube and the
5 sample with a surface or material that has sufficient affinity for the fluid to pull
the sample from the tube.
The above method and system may be used on various parts of the body.
It is particularly appropriate for use on sites other than the fingertips. Although
fingertips provide good blood flow, the high density of pain receptors provide
10 for easy access to blood but maximum pain in sampling. The method of this
invention actively draws a sample from the body, enabling the use of sampling
sites on the body which are inadequate for traditional lancing. Since the method
can also provide a mechanism for the easy transfer of the sample, the difficulty
of bringing the sample to a test device is eliminated. An important benefit of
15 this system is that the use of alternate sites on the body reduces the
accompanying pain sensation and encourages more frequent use as needed.
While the method may be readily used to obtain a blood sample in a
minimally invasive fashion, a sample of interstitial fluid may similarly be
obtained, generally utilizing a less deep puncture in sites with lower blood flow.
20 This will become more important as tests are developed which can utilize ISF
samples, which may be preferred compared to blood.
this invention provides a device and method for lancing a patient and
virtually simultaneously producing and collecting the fluid sample, which may
be transferred to a test device. A preferred device of the present invention
25 comprises a blood collection system including a lancing needle, drive
mechanism, kneading or vibration mechanism and optional suction system and
sample ejection mechanism. The device is preferably sized to be hand-held in
one hand and operable with one hand. The device can optionally contain
integral testing or analysis component for receiving the sample and providing
30 testing or analysis indication or readout for the user.
WO 97/42888
PCT/US97/08762
The lancing needle and firing mechanism designed to create a wound
which will both provide an adequate sample but which will still close and heal
quickly. Wound healing is an especially important consideration for diabetic
patients who often have compromised circulatory systems and slow healing
5 processes. The wound must have a geometry which allows for a momentary
space in which blood can fill, taking into account the elastic nature of the skin
tissues. Careful consideration must be given to these geometries or the dermis
will seal around the lancing needle tip, precluding the drawing of a sample .
through the tip. In a preferred embodiment a needle is used in combination
10 with a flexible collar and outer tube to spread the wound so blood can pool.
Alternatively a multiple needle lancing device can be used to generate a wound
which disrupts multiple capillary areas to quickly provide large sample size, but
the smaller multiple wounds, can heal more easily.
In an alternate embodiment, the needle/lance is withdrawn from the
15 wound, and the area surrounding the wound is massaged or stimulated to
prevent it from closing and to promote the flow of body fluids and or blood to
the wound and to the surface of the skin.
Devices according to this invention create a lancing motion which cuts
into the small but plentiful capillaries in the superficial vascular plexus under
20 the epidermis. This vascularized region starts at a depth of 0.3 - 0.6 mm from
the surface of the skin in many accessible areas throughout the body (forearm,
thigh, abdomen, palm). Blood is in plentiful supply in this region of the skin,
and healing of small wounds is not problematic. However, bringing a sizable
drop of blood to the surface is more problematic than with a finger stick. A
25 finger stick is typically massaged to increase momentary blood flow. This
invention provides a system for mechanically massaging a lance site at other
body locations by several different approaches, including oscillating an annular
ring surrounding the wound to pump the blood surrounding the wound into the
wound for extraction by a needle or capillary tube or oscillating paddles or other
30 members adjacent the wound to achieve the desired blood flow. Further,
bringing a drop of blood from the skin in other regions of the body, e.g., the
-7-
WO 97/42888
PCMJS97/08762
thigh, to a small area on a test device is very difficult. An alternate
embodiment of the present invention works with the needle remaining in the
wound and the needle being mechanically manipulated to promote the formation
of a sample of body fluid in the wound.
5 The needle may be vibrated in any desired and effective motion,
including an up and down motion, a side to side motion, a circular motion, a
rotation motion or any combination thereof. This creates a momentary opening
in which the blood can fill while the device draws the blood through the needle
into the disposable sample collection chamber. The vibration of the needle may
10 occur across a broad range, from 30 cycles per minute up to 1000 cycles per
/ minute or more. This slight vibration does not measurably increase the
sensation felt by the patient, particularly when a short duration time is used, but
does markedly increase the sample volume which may be easily withdrawn from
a given wound and the rate at which the sample volume is produced fromjhe
15 wound. The oscillation can cause the needle to move up to 2 - 3 mm per cycle.
The optimal needle oscillation is less than 1.5 mm, with about 0.5 mm preferred
based on current investigations. Oscillating or rotating the needle from 30
cycles per minute up to 1000 cycles per minute or more holds the wound open
and prevents it from closing and stopping sample collection and provides sample
20 collection in a shorter amount of time.
Lancing conventionally occurs at a 90 degree angle (perpendicular) to the
skin surface. However, we have found that the lancing member may puncture
significantly more capillaries if the lancing is performed on a angle. At a too
shallow angle, no significant depth of penetration is achieved. Lancing at an
25 incident angle of 15 - 90 degrees to the surface of the skin is effective, with
shallower angles producing greater blood flow.
The device and system of this invention can further enhance blood flow
by massaging the site prior to lancing, as well as by massaging the area adjacent
the lancing cite while the lancing member is in the wound and after it is
30 removed from the wound, as well as during sample collection, as described
WO 97/42888
PCIYUS97/08762
above. Alternate methods can use a wiper to rub across or vibrate the skin or
can apply heat to the skin to increase the blood flow to the sampling site.
In another alternate configuration, the lancing needle may be withdrawn
very slightly from the point of maximum penetration to create an opening in
5 which blood can pool before being suctioned through the device. This can be
accomplished with a double stop system which stops the needle at maximum
penetration then stops the retraction of the needle at partial but not full
retraction. The area surrounding the wound can be kneaded or massaged by
optional movable members mechanical to stimulate blood flow to the wound and
10 increase the sample size and the rate of production of the sample. The
mechanical motion can displace the area around the wound from 0.05 to 8 mm,
with 1 - 5 mm being preferred based on current investigations. A wiper device
can be used in the aspect which rubs the skin to increase the blood flow to the
wound by stimulating the capillaries.
15 The mechanical stimulation of the wound can be accomplished by
different methods or motions and members. An annular ring or other polygon
or blade or paddle members may be oscillated around the wound by
piezoelectric, ultrasonic, solenoid/coil, motor and cam or other methods apparent
to one skilled in the art. Mechanical oscillation in the range of 2 to 1000
20 cycles per minute may be employed, with 10 to 400 cycles being preferred.
Ultrasonic vibration has been effective at a frequency as high as 40 kHz.
Alternately, the device may employ* a blade or squeegee type of stimulator
which kneads the site with horizontal or a combination of horizontal and vertical
action and promotes blood flow to the wound. The squeegee may act on the
25 wound area 2 to 200 times per minute, with 60 times per minute preferred based
on current investigations. Additionally, the needle may be vibrated
ultrasonically, with or without the kneading or massaging action adjacent the
wound. The ultrasonic vibration can cover the range of ultrasonic frequencies
depending on the sampling area and whether the needle or the stimulation
30 device is being activated.
WO 97/42888 PCT/US97/08762
In another aspect of this invention the lancing member is contained a
multi-chambered or multi-channelled capillary disposable member wherein one
chamber contains the lancing member and an adjacent chamber is adapted to
receive the blood or fluid exiting the wound. The multi-chambered capillary
5 disposable can be made from any suitable material, and installed in the sampler
so that it is positioned in the appropriate position relative to the wound created
to permit collection of the sample. The lancing device is driven into the skin
and withdrawn by the secondary retraction springs after reaching the limit stops.
After withdrawal of the lancing member, the stimulator ring or other polygon
10 shape is oscillated by one of the various methods to pump blood from the
capillaries adjacenUo the wound. The sampling device of this aspect of the
invention has stop mechanisms to limit the penetration of the lancing member
and sample duration system which sets the time of the sample collection. The
lancing guide chamber can be formed a variety of ways and one skilled in the
15 art can reconfigure it to create alternate embodiments.
In another aspect similar to the above, the lancing member can be
contained within a single capillary tube and adapted to extend from the end of
the tube to create the wound. The lancing member then retracts a sufficient-
distance inside the capillary to allow the desired sample to be collection in the
20 end of the same capillary tube in the space below the retracted lancing member.
In such an embodiment the lancing member can be vibrated in the wound before
retraction, also as described above.
To achieve the sample collection after withdrawing the needle, a
stimulator ring can be used to pump the sample from the surrounding capillaries
25 through the wound opening. The stimulator ring is designed to keep the skin
taut to allow better penetration of the skin during lancing and help keep the
wound open during pumping. It can be oscillated appropriately to insure that
enough sample is pumped from the local capillaries. The time or number of
cycles varies by individual and location being sampled. To achieve a variable
30 sample time either of the following methods may be used. A sensor can be
built into the sampler which senses the blood in the collection chamber or
- 10-
WO 97/42888
PCT/US97/08762
device. When an adequate sample level (which may be adjustable) is reached,
the stimulation mechanism is turned off. A second method is to have a patient
definable input which sets the time duration for the test or the number of cycles
for the stimulation ring. Additional stimulator motions can be employed to
5 promote the extraction of bodily fluids. These include sinusoidal motion,
wobbling, kneading or peristaltic motion. An alternate stimulator device can be
designed with an inner and outer ring which will alternate creating a peristaltic
pumping motion on the capillaries surrounding the wound. Another alternate
stimulator device uses a spiral spring that can be compressed flat to emulate
- 10 multiple pumping rings. As will be apparent, various configurations of multiple
stimulator rings, paddles, or other members, used in various rhythms and orders
of movement can be employed in the present invention. The stimulator ring or
member can be heated in order to heat the skin to increase the capillary volume
flow to and out of the wound. In addition, the housing or case of the device or
15 other components of the device can be heated to provide heating of the skin.
In another aspect of the invention a diffused laser may be used to
penetrated to the superficial vascular plexus and a capillary tube may be used to
collect the sample. A lens may be used to diffuse the laser so that it does not
create a large wound or damage large areas of skin and tissue. A minimum
20 wound size is important to enable rapid healing. The capillary collection tube
can use a suction generator to draw the sample up the tube and can also utilize
an optional stimulator ring to pump the blood from the adjacent capillary beds.
In another aspect of the invention the lancing can be accomplished by a
pulse of a fluid under high pressure such as a liquid or a compressed gas. In
25 addition the compressed gas can be directed, at lower pressure, to the skin
surface to massage the skin before lancing, during lancing and/or during sample
collection. Pulsing the compressed gas against the skin at desired pressures,
patterns and intervals, including sequential pattern across the surface of the skin,
can provide the desired stimulation of the blood flow into and from the wound.
30 The pulse of compressed gas used to perform the lancing and opening of the
wound can be a single pulse or multiple pulses, can be directed through a
- 11 -
WO 97/42888
PCTAJS97/08762
capillary sample collection tube, and/or can be applied vertically to the skin
surface or at an angle, as described above for other lancing members, to achieve
puncturing the maximum capillaries in the skin and provide the sample
collection in a short period of time.
5 In another aspect of the invention an off meter test device is used with a
sampler of this invention to provide an integrated sampling and testing device.
This device can be used by the patient to essentially simultaneously draw a
sample and test for the presence or concentration of an analyte in a body fluid.
The sample can be taken from an alternate location other than the fingertips
10 with the device of this invention. To accomplish this it is critical to the test to
provide a mechanism to stimulate the wound and or the surrounding area to
provide an adequate sample for the test device. This stimulation can be
accomplished by manipulating the needle or the area of skin surrounding the
wound as described above. A combination of the two methods can be employed
15 to increase the volume and/or decrease the sampling time. The sample is
introduced directly into a test device or testing area rather than being collected
and subsequently dispensed.
In another aspect, this invention also provides a method of determining
the correct sample size prior to transferring or testing. Different methods can be
20 used to sense the volume and/or presence of the sample. One system uses two
contacts to sense the presence and/or volume of a sample. The body fluid either
is drawn up a tube or wells up on the surface of the skin where it creates a short
between two contacts which signal that the proper sample has been drawn. An
alternate system uses an LED and receiver. When the sample rises to the level
25 where it blocks the LED from the receiver the proper sample has been drawn.
Other optically activated or contact activated systems can be used in this aspect
of the invention.
In another aspect, this invention also provides a method of making a unit
with a disposable section to limit biohazard cross contamination.
30 In another aspect, this invention provides a bell shape capillary tube.
The capillary tube wicks the sample up the tube until it reaches the transition of
- 12 -
WO 97/42888
PCT/US97/08762
the bulb. The bulb is then depressed to expel the sample or a known volume of
the sample to a desired location, such as a test strip or device for analysis. The
bell shape can be designed as a cone and the sample is wicked up the cone and
dispensed by reversing the cone and expelling the sample by capillary action
5 . onto the test device.
In an alternate embodiment the device of this invention lances and
stimulates the area, creating a drop of sample fluid, which is collected on or
transferred directly to a test device by applying the test device to the drop.
In another aspect, this invention can also include an auto-injection
10 device. A preloaded tip may be placed into the barrel. The trigger and spring
system can be designed to deliver the sample from the syringe rather than to
collect a sample into the syringe. One who is skilled in the art could readily
reconfigure the mechanism described to inject a sample. Moreover, the device
may have dual function of collecting a sample while simultaneously or
15 sequentially injecting a sample, which can be in response to a test performed in
the device on the sample collected
Brief Description of Drawings
Figure 1 shows a device of this invention having a double stop
mechanism.
20 Figure 2A and Figure 2B are cross section views of a device of this
invention in the cocked and the deployed position, respectively.
Figure 3 shows a longitudinal cross section of a device according to this
invention having a stimulator member proximate to the lancet or needle.
Figure 4 shows the stimulator member positioned on the skin of the
25 patient adjacent the wound and the lance.
Figure 4A provides a schematic layout of the skin illustrating where the
superficial vascular plexus capillaries are relative to the skin's surface.
Figure 4B is a representation of a wound, shown in cross section, which
will facilitate the formation of a small pool of blood yet ensure that the skin
30 will fully contract around the wound following sampling to promote healing.
The relationship of the wound, needle and the superficial vascular plexus
- 13 -
WO 97/42888
PCTYUS97/08762
capillaries is also illustrated. In the embodiment shown the capillary is offset in
the needle.
Figures 4C and 4D show alternative embodiments in which, to enhance
sample collection and minimize the wound size required, the needle may be
5 vibrated mechanically in either an up and down motion as shown in Figure 4C
or a side to side as shown in Figure 4D.
Figure 4E shows that the needle may be vibrated ultrasonically with or
without the kneading or massaging action.
Figures 4F and 4G show that the area surrounding the wound can be
10 kneaded by optional mechanical motion to stimulate blood flow to the wound
and increase the sample size and the rate of production of the sample. /
Figure 4H shows that, alternately, the device may employ a squeegee
type of stimulator which kneads the site with horizontal or a combination of
horizontal and vertical action and promotes blood flow to the wound.
15 Figure 41 shows an alternate embodiment in which needle is oscillated or
rotated.
Figures 5A and 5B show front and side views of a replaceable needle
with a spade tip design adapted for use in this invention, especially for a
moving/rotating needle for holding a wound open during sample collection.
20 Figures 6 A and 6B illustrate a front and side view of a disposable needle
that has an eccentric passageway for sample collection. The needle can have a
luer lock type connection to the sample device of this invention.
Figure 7 shows a needle with a collar or sleeve to provide mechanical
spreading of the wound during sample collection.
25 Figures 8A and 8B are longitudinal cross section views of a device with
a multi-chambered capillary members accommodating a lancet or needle in one
chamber and providing another chamber or conduit for sample collection.
Figures 8C, 8D and 8E are top view cross section views of two and three
chamber capillary members.
- 14-
WO 97/42888
PCT/US97/08762
Figure 9A and 9B illustrate a longitudinal cross section of a device
having a multi-chambered capillary disposable and peristaltic pump to collect a
sample.
Figure 9C illustrates in cross section an alternate suction/standoff/lance
5 disposable tip containing contacts for electrically sensing the presence and/or
volume of body fluid.
Figure 10 illustrates in cross section a device with a laser positioned to
radiate through the interior of the needle or capillary for piercing the skin.
Figure 1 1 illustrates in longitudinal cross section in cross section a
10 device of this invention for use with a combined suction/standoff chamber as
part of a disposable sample collection system.
Figures 12A and 12B illustrate a longitudinal cross section and side view
cross section of a device of this invention having and angled lancet or needle
and employing an absorbent strip.
15 Figures 13 and 14 show a longitudinal cross section and a side view
cross section of a sampling device of the present invention with an integrated
colorimetric instrument test.
Figure 15 shows a longitudinal cross section of an sampling device of
the present invention with an integrated electrochemical test.
20 Figures 16 and 17 show a longitudinal cross section and a side view
cross section of a sampling device of the present invention with an integrated
colorimetric visual test.
Figure 18 shows an alternate device which has a completely disposable
lower section to minimize blood contamination between uses.
25 Figure 19A shows the combination of a dual alternating stimulation ring
system.
Figure 19B shows the device with a telescoping stimulator ring.
Figures 20A, 20B and 20C illustrate a bell shape capillary tube and
Figure 20D shows a straight capillary tube with a test strip.
50 Figure 21 illustrates a device of this invention with a member to oscillate
the needle to stimulate fluid flow from the wound.
WO 97/42888
PCT7US97/08762
Figure 22A shows a multiple needle lancing device.
Figure 22B shows a broader single lancet.
Figures 22C and 22D show a die cut sheet which has small multiple
barbs formed in the sheet for use as a lance in the present invention.
5 Description of the Invention
Figure 1 illustrates a minimally invasive sampling device according to
the invention. The device is comprised of numerous components which will be
more fully described below. The main body 1 supports the various mechanical
components housed within the device.
10 The main body 1 comprises an elongated hollow cylindrical tube with
openings at both ends. The sampling needle 16 which is part of the disposable
3 which is capable of being retracted or deployed so that it can protrude beyond
the needle guard 17 is positioned at one end. The arming and dispensing
plunger 22 protrudes from the other end. The device has a needle guard 17
15 which permits the loading of the disposable 3. Disposable 3 is attached to the
syringe 13 and plunger 14 is released by the suction cam 8.
The syringe 13 is captivated to the drive system by syringe clamp 12
which has .the main tie rods 4 anchored to it. The main drive springs 1 1 are
captivated between the syringe clamp 12 and cross support 10 and the tie rods 4
20 are threaded through them.
The main tie rods 4 have the main cams 9 attached to them and are
supported by the activation trigger 2 prior to release. The secondary springs 21
and secondary stops 20 provide a mechanism after activation to pull the needle
back out of the wound to permit blood accumulation. When the skin is pierced
25 the secondary springs 20 retract the needle from the wound triggering the
suction cam 8 and plunger 14 is released. The arming and dispensing plunger
22 is a dual purpose device. When the patient pulls up, it preloads the drive
springs 11. It is latched by pushing in on the activation trigger 2.
The stop and adjustment tabs 19 control the depth of penetration of the
30 needle 16 so that the optimal depth of penetration is reached for a particular
sample site. The sample 15 is drawn from the patient when the device has been
- 16-
WO 97/42888 PCT/US97/08762
deployed by releasing the activation trigger 2 and the needle 16 has been
retracted from the patient.
The system shown in Figure 2A and 2B is comprised of a reusable barrel
1 and associated mechanisms and a sterile disposable 13. The disposable 13 has
5 an ultra fine gauge needle 16 which is imbedded in a cap until the device is
readied for use. Figure 2B shows the device in the deployed state with a
sample in disposable 13 and figure 2A shows it undeployed.
Main yoke 3 is held by activation triggers 2 which support the main tie
rods 4 when the system is undeployed. The system is activated by releasing the
10 activation triggers 2. This releases the main cam 9 which causes the syringe to
be deployed by the drive spring 11 which is captured between the cross support
10 and the syringe clamps 12. The needle 16 pierces the skin as a result of
these actions and the penetration depth is controlled by stop 27. When the
suction cams 8 is released by the secondary trigger 5, the suction spring 6 is
15 released. This drives the suction yoke 7 up slowly due to the damping action of
the syringe plunger 14 so a back pressure or vacuum is created in the syringe
body. Sample 15 is actively drawn into the syringe.
The sample can be delivered easily and precisely to a test device or other
container by pressing down on a button on the top of the sampler. The
20 disposable syringe 13 and needle 16 may be imbedded in the cap in which it
was shipped or placed into a Sharps container for safe disposal.
To insure that adequate sample size is collected the needle 16 can be
vibrated, oscillated or rotated to keep the wound from closing. The disclosure
of Figures 3, 4, 4C, 4D f 4E f 41, 9, 12 and 13 show and describe various
25 alternative motions that can be used to accomplish this.
Another version of this device is also capable of performing as an auto-
injection device. A preloaded tip may be placed into the ban-el. The trigger
and spring system can be designed to deliver the sample from the syringe rather
than to collect a sample. One who is skilled in the art could readily reconfigure
30 the mechanism described to inject a sample.
- 17-
WO 97/42888
PCT/US97/08762
Figure 3 illustrates a minimally invasive sampling device according to
the invention. The device is comprised of numerous components which will be
more fully described below. The main body 1 supports the various mechanical
components housed within the device.
5 The main body 1 comprises an elongated hollow cylindrical tube with
openings at both ends. The sampling needle 16 which is part of the disposable
3 which is capable of being retracted or deployed so that it can protrude beyond
the needle guard 17 is positioned at one end. The arming and dispensing
plunger 22 protrudes from the other end. The device has a needle guard 17
10 which can be slid up and down main body 1 by the patient to permit the loading
of the disposable 3. Disposable 3 is attached to the syringe 13 by the tip
adapter 18. The internal parts of the syringe 13 are the plunger 14 which is
activated by the suction spring 6 and the suction yoke 7. The plunger is
released when the suction cam 8 is released by the secondary trigger 5.
15 The syringe 13 is captivated to the drive system by syringe clamp 12
which has the main tie rods 4 anchored to it. The main drive springs 11 are
captivated between the syringe clamp 12 and cross support 10 and the tie rods 4
are threaded through them.
The main tie rods 4 have the main cams 9 attached to them and are
20 supported by the activation trigger 2A prior to release. The secondary springs
21 and secondary stops 20 provide a mechanism after activation to pull the
needle back out of the wound to permit blood accumulation. When the skin is
pierced the secondary springs retract the needle from the wound and initiate the
stimulation ring 25 oscillation system 26 and 27 to force blood flow to the
25 wound. The arming and dispensing plunger 22 is a dual purpose device. When
the patient pulls up, it preloads the drive springs 11. It is latched by pushing in
on the activation trigger 2A.
The stop and adjustment tabs 19 control the depth of penetration of the
needle 16 so that the optimal depth of penetration is reached for a particular
30 sample site. The stimulator ring can be deployed during lancing to keep the
skin taut, thus allowing more accurate and repeatabie penetration of the skin.
- 18-
WO 97/42888
PCT/US97/08762
The sample 15 is drawn from the patient when the device has been deployed by
releasing the activation trigger 2 and the needle 16 has been retracted from the
patient.
Figure 4 illustrates the relationship of the needle 16, wound 200 and
5 stimulation ring 25. The detail areas of the skin are shown for clarity. The
stimulator ring 25 is used to pump the sample of body fluid 61 into wound area
200, A singular stimulation ring 25 is shown in this illustration. However,
multiple telescoping rings may be employed to enhance the blood transport.
The stimulation ring can also be formed to with a series of notches to
10 permit the resupply of body fluid to the capillaries when the stimulation ring 25
z is retracted from the wound site 200.
In an alternate embodiments the stimulation ring is heated or a secondary
motion added to act as a wiper to enhance the flow of body fluid to the wound
200. Other members can be used instead of a ring to provide the stimulation
15 desired.
Figures 4C, 4D and 4E illustrate that the needle may be vibrated in the
desired motion. This creates a momentary opening in which the blood can Fill
while the device draws the blood through the needle into the disposable sample
collection chamber. The vibration of the needle may occur across. a broad
20 range, from 30 cycles per minute up to 1000 cycles per minute or more. This
slight vibration does not measurably increase the sensation felt by the patient
but does markedly increase the sample volume which may be easily withdrawn
from a given wound and the rate at which the sample volume is produced from
the wound. The oscillation can cause the needle to move up to 2 - 3 mm per
25 cycle. The optimal needle oscillation is less than 1.5 mm, with about 0.5 mm
preferred based on current investigations. Lancing generally occurs at a 90
degree angle (perpendicular) to the skin surface. However, the lancing member
may puncture significantly more capillaries if the lancing is performed on a
angle. At a very shallow angle, no significant depth of penetration is achieved.
30 ' Lancing at an incident angle of 15 -90 degrees to the surface of the skin is
effective, with shallower angles producing greater blood flow. The ultrasonic
- 19-
WO 97/42888
PCT/US97/08762
vibration can cover the range of ultrasonic frequency depending on the sampling
area and whether the needle or the stimulation device is being activated.
Figures 4F and 4G show massaging or kneading the area surrounding the
wound. The mechanical motion can displace the area around the wound from
5 0.05 to 8 mm, with 1 - 5 mm being preferred based on current investigations.
Figure 4G shows a wiper device which rubs the skin to increase the blood flow
to the wound by stimulating the capillaries. This action can also be done by
the patient by rubbing the area to increase the blood flow to the sampling site
prior to taking a sample. The oscillation can be accomplished via piezoelectric,
10 ultrasonic, or by using a solenoid/coil or a motor and cam. Mechanical
oscillation in the range of 2 to 1000 cycles per minute may be employed, with
20 to 200 cycles being preferred. Ultrasonic vibration has been effective at a
frequency as high as 40 kHz. Figure 4F shows an alternate embodiment in
which the wound is mechanically stimulated such as by an annular ring which
15 may be oscillated.
Figure 4H shows massaging with a squeegee type of stimulator. Such a
squeegee may act on the wound area 2 to 200 times per minute, with 60 times
per minute being preferred.
Figure 41 shows rotating or oscillating the needle from 30 cycles per
20 minute up to 1000 cycles per minute or more. This holds the wound open and
prevents it from closing and stopping sample collection. This embodiment can
employ the needles disclosed herein in Figures 4B, 5A, 5B, 6A and 6B,
conventional needles or round or flat lancets.
Figures 5A and 5B show a spade tip needle/lance profile which is used
25 by the invention to create a void area in the wound. Figures 5 A and 5B show
one needle profile which is useful in implementing this embodiment. The spade
end helps create a void area when it is rotated in the small wound.
Figures 6A and 6B show an asymmetric needle design to create a wound
which can enhance capillary blood collection. Needle 16 is molded to form
30 disposable 3. Another aspect of the invention is the provision of an easily
replaceable lancing tip (Figure 6A and 6B). The tip must attach to the device
-20-
WO 97/42888
PCIYUS97/08762
simply to facilitate the availability of a fresh, sterile needle for each sample
drawn. A wide range of lancet or needle gauges may be used for the tip.
Current investigations show that 10 through 32 gauge is acceptable depending
on the sampling location. The entire device may also be designed as a single
5 use device. In this configuration, the device would be precocked and would
only trigger and dispense once. A new device with a sterile tip would be thus
used for each sample drawn. It will be apparent that an alternate disposable can
be constructed from a needle and flexible tube. The tube acts as a reservoir for
the sample as it is drawn by the applied vacuum. Another capillary type
10 disposable is shown in figure 31. The bell type disposable uses capillary action
to wick the sample up the tube until it reaches the bulb or vacuum created by
depressing the bulb. The sample is dispensed by collapsing the bulb. Anyone
skilled in the art would be able to readily reconfigure the design presented
herein to be a single use device.
15 Figure 7 illustrates the use of a needle 16 with a flexible collar 225
and stimulator ring 25 to hold the wound open during the extraction of the body
fluid sample. The collar 225 is affixed to the needle and acts as a stop and as a
means of spreading the wound. This provides a means of forcing the wound
open during sampling. The collar 225 can be fashioned in various
20 configurations to achieve the same results by one skilled in the art.
Figure 8A shows the lancing member is part of a multi-chambered
capillary disposable. Figure 8B provides an exploded view of the end of the
device showing the relation ship of lancet 30, disposable 33 and lancet guide
tube 35. The multi-chambered capillary disposable can be made from any
25 suitable material. Figures 8C, 8D and 8E show various alternatives of this
embodiment One skilled in the art could readily reconfigure a disposable
which would be equal to this invention.
The lancet 30 creates the wound and is guided by guide tube 35. The
sample is drawn up the sample collection tube/disposable 33. The complete
30 device can either be fashioned as one single disposable or multiple components.
-21 -
WO 97/42888
PCT/US97/08762
Figures 9A illustrates a minimally invasive sampling device according to
the invention using the alternate capillary disposable blood collection device
Figure 8A which is disposable 33. The device is comprised of numerous
components which will be more fully described below. The main body 1
5 supports the various mechanical components housed within the device. Figure
9B shows the cutout to allow communication of blood to the sample collection
tube.
The main body 1 comprises of an elongated hollow cylindrical tube with
openings at both ends. The capillary sampling disposable with lancing member
10 30, which is part of disposable 33 and is capable of being retracted or deployed
so that it can protrude beyond the end of the main body 1, is positioned at one
end. The arming plunger assembly 36 protrudes from the other end. The
lancing member 30 is guarded by being withdrawn into the needle guide tube 35
which is part of the disposable 33, The needle guide tube 35 acts as the lancing
15 guide and lancet guard. The disposable 33 is attached to the main body 1 so
that it is positioned at the appropriate location to guide the lancet and suction up
the blood. The striker 39 is projected so as to drive the lancet into the patient
41 by the spring 43 and the arming plunger assembly 36. The arming plunger
is locked in place by a cam 45 and trigger 47. A double stop return spring 49
20 is located and sized to return the lancet 30 back into the disposable 33 needle
guide tube 35. The needle guard 17 supports the main body 1 on patient 41.
The double stop return springs 49 provide a mechanism after activation
to pull the needle back out of the wound to permit blood 61 accumulation.
When the skin is pierced the secondary springs 49 retract the needle from the
25 wound and initiate the stimulation ring 25 oscillation system to force blood
flow to the wound. The stimulator ring can oscillate in the preferred range of 1
to 5 mm. The frequency can vary from 5 to 1000 cycles per minute in the
preferred embodiment The oscillation of the stimulator ring 25 is driven by the
coils 51 which oscillate the stimulator ring 25 to pump the blood 61 from the
30 surrounding capillaries in the skin into the wound. Each down stroke of the
stimulator ring 25 provides this pumping action. This pumping action can be
-22-
WO 97/42888
PCT/US97/08762
modified to include sinusoidal motion, wobbling, kneading or peristaltic motion
which will enhance the blood flood to the wound.
A linkage 53 drives a peristaltic roller system 55 and rollers 57 against
the suction tube 59 causing blood 61 to be drawn up the suction tube 59
5 creating the sample 15.
The stop and adjustment tabs 19 control the depth of penetration of the
lancet 30 so that the optimal depth of penetration is reached for a particular
sample site.
In another aspect of this invention, electric potential can be applied
10 across the skin to also stimulate blood flow to the wound. This can be
accomplished by having separate electrodes present in the device to contact the
skin and deliver the electric current at locations desired. Or, the current can be
delivered to the skin through components of the device, appropriately insulated
internally of course, such as the stimulator ring 25 and sample tube 59, or any
15 other appropriate combination. In general, low voltage DC or AC current can
aid in blood flow. The voltage, amperage and cycles (in the case of AC) can be
determined by one skilled in the art, but DC voltage in the range of 1 millivolt
to 12 volts will be useful. Likewise, the duration of the applied current or the
pulsing thereof can be selected as desired. In a particular example tube 33 in
20 Figure 9A or needle 16 in Figure 3 can be the negative electrode and ring 25 in
Figure 9A and Figure 3 or guard 17 can be the positive electrode.
Figure 9C illustrates a alternate suction/stand off chamber blood
collection device 72 which comprises of lance 30, suction tube 59, secondary
tube which guides the lance 30, suction/standoff chamber 105, and contacts 107
25 and 109. The suction tube 59 is mounted in suction/standoff chamber 105 so as
to permit the suction tube to be located off the wound to promote bleeding
while the wound is stimulated. The contacts provide a means of determining if
the sample size is adequate. Contacts 109 are made when adequate volume of
blood is present in the cap 105 and these are in communication with contacts
30 107 which are in communication with the electronic package of the sampler.
-23 -
WO 97/42888
PCT/US97/08762
Once contacts 109 are made by the blood then the circuit is completed signaling
the system to stop.
Figure 10 illustrates a minimally invasive sampling device according to
the invention using the alternate capillary disposable blood collection device and
5 laser 67 lancing mechanism. The device is comprised of numerous components
which will be more fully described below. The main body 1 supports the
various mechanical components housed within the device.
The main body 1 is comprised of an elongated hollow cylindrical tube
with openings at both ends. The capillary sampling disposable with diffusing
10 lens member 60 which is part of disposable 63 is installed in one end of the
main body 1. The firing switch 65 protrudes from the other end. The capillary
tube 59 acts as the laser guide and sample collection device. The disposable 33
is attached to the main body 1 so that it is positioned at the appropriate location
to direct the laser and to suction up the blood. The laser 67 is diffused by
15 going through the lens and creates the wound in the patient.
When the skin is pierced, the laser shuts down. This initiates the
stimulation ring 25 oscillation system to force blood flow to the wound. The
oscillation of the stimulator ring 25 is driven by the coils 51 which oscillate the
stimulator ring 25 so as to pump the blood 61 from the surrounding capillaries
20 in the skin into the wound. Each down stroke of the stimulator ring 25 provides
this pumping action. A linkage 53 drives a peristaltic roller system 55 and
rollers 57 against the suction tube 59 causing blood 61 to be drawn up the
suction tube 59 creating the sample 15. The oscillation of the stimulator ring
can have a range of 0 to 8 mm and preferably 1 to 5 mm. The frequency can
25 also vary from 2 to 100 cycles per minute.
In an alternative embodiment for the device of Figure 10, the lancing
means can be a liquid under high pressure or a compressed gas pulse instead of
the laser. A pulse of compressed gas, or multiple pulses, can be directed at the
skin. In addition, the liquid under pressure or compressed gas pulses can be
30 applied in the annular space between ring 25 and housing 1 to massage and
stimulate the skin to increase blood flow to the wound.
-24 -
WO 97/42888
PCT/US97/08762
It is to be understood that the vacuum employed in the various
embodiments of this invention can be used with the capillary tubes, such as 59
in Figure 10, as well as the needles of Figures 4B, 5A and B, and 6A and B.
Figure 11 illustrates a minimally invasive sampling device according to
5 the invention using the alternate suction/stand off chamber blood collection
device 72 which is more fully described in illustration 9C The device is
comprised of numerous components which will be more fully described below.
The main body is 1 which supports the various mechanical components housed
within the device.
10 The main body 1 comprises of an elongated hollow cylindrical tube with
openings at both ends. The suction/stand off chamber sampling disposable with
lancing member 30 which is part of disposable 72 and is capable of being
retracted or deployed so that it can protrude beyond the end of the main body 1
positioned at one end. The arming tabs/trigger 37 protrude from the sides of
15 main body 1. The disposable 72 is attached to the main body 1 so that it is
positioned. at the appropriate location to guide the lancet and suction up the
blood. The striker 39 is projected so as to drive the lancet into the patient 41
by the spring 43 and the arming plunger assembly 37. The arming plunger is
locked in place by a cam 45 and trigger 37. A double stop return spring 49 is
20 located and sized to return the lancet 30.
In another aspect, the capillary sample collection tubes used in the
various embodiments of this invention, such as 33 in Figures 8A and 9 A, 59 in
Figure 9C and 10 and 150 in Figures 20A-20C, can be selected to have an
affinity for the sample fluid greater than the skin so the fluid or blood will wick
25 into the tube by capillary action. However, the capillary tube is also selected to
have less affinity for the sample fluid or blood than a test strip or test device
surface of receiving port so that the sample fluid or blood will wick out of the
capillary tube into or onto the test strip or device. Such materials for the
capillary tube can easily be determined and selected by one skilled in the art,
30 but generally capillary, tubes of nylon, PTFE, and the like generally fulfill this
function. It will be recognized that the selection of such material for the
- 25 -
WO 97/42888
PCTYUS97/08762
capillary tube must be made relative to the materials present in and the physical
construction the test strip or device, if this aspect of the present invention is to
be utilized.
The double stop return springs 49 provide a mechanism after activation
5 to pull the needle back out of the wound to permit blood 61 accumulation.
When the skin is pierced, the secondary springs 49 retract the needle from the
wound and initiate the stimulation ring 25 oscillation system to force blood flow
from the wound. The stimulator ring can oscillate in the preferred range of 1 to
5 mm. The frequency can vary from 5 to 1000 cycles per minute in the
10 preferred embodiment. The oscillation of the stimulator ring 25 is driven by the
motor 51 which oscillate the stimulator ring 25 to pump the blood 61 in the
surrounding skin capillaries from the wound so the blood can flow to the surface
of the skin, bead up, and contact the disposable 72. Each down stroke of the
stimulator ring 25 provides this pumping action. The disposable 72 is then
15 lowered onto the blood bead using a secondary motion spring 74 that is released
by a secondary motion trigger 75, and suction of the blood initiated. The
suction device 85 shown here is a mini syringe which is activated by spring 86
when secondary motion trigger 75 is released causing blood 61 to be drawn up
the disposable 72. The stop and adjustment cap 19 controls the depth of
20 penetration of the lancet 30 so that the optimal depth of penetration is reached
for a particular sample site.
Figures 12A and 12B illustrate a minimally invasive sampling device
according to the invention using a disposable piercing apparatus, a reusable
sampling device and a disposable absorbent test strip 83. Figure 12A shows the
25 device in a side view and Figure 12B is a front view. The device is comprised
of numerous components which will be more fully described below. The main
body is 1 which supports the various mechanical components housed within the
device.
The main body 1 comprises of an elongated hollow cylindrical tube with
30 openings at both ends. The lancing member 30 which is part of disposable 33
is capable of being retracted or deployed so that it can protrude beyond the end
-26-
WO 97/42S88 PCT/US97/08762
of the main body 1 is positioned at one end. The arming tabs 37 protrude from
the sides of main body 1. The lancing member 30 is guarded by being
withdrawn into the tube 35 which is part of the disposable 33. The tube 35 acts
as the lancing guide and lancet guard. The disposable 33 is attached to the
5 main body 1 so that it is positioned at the appropriate location to guide the
lancet and is held in place by the disposable clamp 3. The striker 39 is
projected so as to drive the lancet into the patient 41 by the spring 43 and the
arming plunger assembly 36. The arming plunger is locked in place by a cam
45 and trigger 47. A double stop return spring 49 is located and sized to return
10 the lancet 30 back into the tube 35.
The double stop return springs 49 provide a mechanism after activation
to pull the needle back out of the wound to permit blood 61 accumulation.
When the skin is pierced the secondary springs 49 retract the needle from the
wound and initiate the stimulation ring 25 oscillation system to force blood
15 flow to the wound. The cam 55 oscillates the oscillator ring 57 which transmits
the motion to stimulation ring 25. The stimulator ring can oscillate in the
preferred range of 1 to 5 mm. The frequency can vary from 5 to 1000 cycles
per minute in the preferred embodiment. The oscillation of the stimulator ring
25 is driven by the motor 51. The battery 56 provides energy to run the motor
20 51 which oscillates the stimulator ring 25 to pump the blood 61 from the
surrounding capillaries in the skin into the wound. Each down stroke of the
stimulator ring 25 compresses the stimulator spring 53 which provides the return
motion for the stimulator ring 25. . The disposable chemical strip 83 is then
lowered onto the blood bead using a secondary motion spring 74 that is released
25 by a secondary motion trigger 75. The blood is absorbed by the disposable
chemical strip 83 which fits into a slot in the main body 1 and the stimulator
ring 25.
The stop and adjustment tabs 19 control the depth of penetration of the
lancet 30 so that the optimal depth of penetration is reached for a particular
30 sample site.
-27-
WO 97/42888
PCT/US97/08762
Figures 13 and 14 illustrate an integration of the minimally invasive
sampling device with a chemical test measurement, such as glucose, and
electronic readout according to the invention using a disposable piercing
apparatus 33, a reusable sampling device 1, a disposable absorbent test strip 83,
5 and a method of readout such as colorimetric test which is read electronically
and has an electronic readout system. Figure 13 shows the device in a side view
and Figure 14 is a front view. The device is comprised of numerous
components which will be more fully described below. The main body is 1
which supports the various mechanical and electrical components housed within
10 the device.
The main body 1 comprises of an elongated hollow cylindrical tube with
openings at both ends. The lancing member 30 which is part of disposable 33
is capable of being retracted or deployed so that it can protrude beyond the end
of the main body 1 is positioned at one end. The arming tabs 37 protrude from
15 the sides of main body 1, The lancing member 30 is guarded by being
withdrawn into the tube 35 which is part of the disposable 33. The tube 35 acts
as the lancing guide and lancet guard. The disposable 33 is attached to the
main body 1 so that it is positioned at the appropriate location to guide the
lancet and is held in place by the disposable clamp 3. The striker 39 is
20 projected so as to drive the lancet into the patient 41 by the spring 43 and the
arming plunger assembly 36. The arming plunger is locked in place by a cam
45 and trigger 47. A double stop return spring 49 is located and sized to return
the lancet 30 back into the tube 35.
The double stop return springs 49 provide a mechanism after activation
25 to pull the needle back out of the wound to permit blood 61 accumulation.
When the skin is pierced the secondary springs 49 retract the needle from the
wound and initiate the stimulation ring 25 oscillation system to force blood
flow to the wound. The cam 55 oscillates the oscillator ring 57 which transmits
the motion to stimulation ring 25. The stimulator ring can oscillate in the
30 preferred range of 1 to 5 mm. The frequency can vary from 5 to 1000 cycles
per minute in the preferred embodiment. The oscillation of the stimulator ring
-28 -
WO 97/42888
PCT/US97/08762
25 is driven by the motor 51. The battery 56 provides energy to run the motor
51 which oscillates the stimulator ring 25 to pump the blood 61 from the
surrounding capillaries in the skin into the wound. Each down stroke of the
stimulator ring 25 compresses the stimulator spring 53 which provides the return
5 motion for the stimulator ring 25. . The disposable chemical strip 83 is then
lowered onto the blood bead using a secondary motion spring 74 that is released
by a secondary motion trigger 75, and suction of the blood initiated. The blood
is absorbed by the disposable chemical strip 83 which has been manufactured
into the disposable 33. The strip is then read in place by a LED 88
10 colorimetric system and analyzed by electronics which are part of the device and
displayed on display 84.
The stop and adjustment tabs 19 control the depth of penetration of the
lancet 30 so that the optimal depth of penetration is reached for a particular
sample site.
15 Figure 15 illustrates an integration of the minimally invasive sampling
device with a chemical test measurement, such as glucose, and electronic
readout according to the invention using a disposable piercing apparatus 33, a
reusable sampling device l t a disposable absorbent test strip 83, and a method
of readout such as a electrochemical test which is read electronically and has an
20 electronic readout system. The device is comprised of numerous components
which will be more fully described below. The main body is 1 which supports
the various mechanical and electrical components housed within the device.
The main body 1 comprises of an elongated hollow cylindrical tube with
openings at both ends. The lancing member 30 which is part of disposable 33
25 is capable of being retracted or deployed so that it can protrude beyond the end
of the main body 1 is positioned at one end. The arming tabs 37 protrude from
the sides of main body 1. The lancing member 30 is guarded by being
withdrawn into the tube 35 which is part of the disposable 33. The tube 35 acts
as the lancing guide and lancet guard. The disposable 33 is attached to the
30 main body 1 so that it is positioned at the appropriate location to guide the
lancet and is held in place by the disposable clamp 3. The striker 39 is
-29-
WO 97/42888
PCT/US97/08762
projected so as to drive the lancet into the patient 41 by the spring 43 and the
arming plunger assembly 36. The arming plunger is locked in place by a cam
45 and trigger 47, A double stop return spring 49 is located and sized to return
the lancet 30 back into the tube 35.
5 The double stop return springs 49 provide a mechanism after activation
to pull the needle back out of the wound to permit blood 61 accumulation.
When the skin is pierced the secondary springs 49 retract the needle from the
wound and initiate the stimulation ring 25 oscillation system to force blood
flow to the wound. The cam 55 oscillates the oscillator ring 57 which transmits
10 the motion to stimulation ring 25. The stimulator ring can oscillate in the
preferred range of 1 to 5 mm. The frequency can vary from 5 to 1000 cycles
per minute in the preferred embodiment. The oscillation of the stimulator ring
25 is driven by the motor 51. The battery 56 provides energy to run the motor
51 which oscillates the stimulator ring 25 to pump the blood 61 from the
15 surrounding capillaries in the skin into the wound. Each down stroke of the
stimulator ring 25 compresses the stimulator spring 53 which provides the return
motion for the stimulator ring 25. The disposable test strip 83 is then lowered
onto the blood bead using a secondary motion spring 74 that is released by a
secondary motion trigger 75, and suction of the blood initiated. The blood is
20 absorbed by the disposable chemical strip 83 which has been manufactured into
the disposable 33. The strip is then read in place by a milliamp/or millivolt
sensing electronics depending on the specific chemistry of the test strip. This
reading is converted into a chemical concentration by the onboard electronics
and displayed on the LCD on the side of the device.
25 The stop and adjustment tabs 19 control the depth of penetration of the
lancet 30 so that the optimal depth of penetration is reached for a particular
sample site.
Figures 16 and 17 illustrate an integration of the minimally invasive
sampling device with a chemical test measurement, such as for glucose, using
30 a disposable piercing apparatus 33, a reusable sampling device 1, a disposable
absorbent test strip 83 capable of providing semiquantitative colorimetric results.
-30-
WO 97/42888 PCT/US97/08762
The device is comprised of numerous components which will be more fully
described below. The main body is 1 which supports the various mechanical
and electrical components housed within the device.
The main body 1 comprises of an elongated hollow cylindrical tube with
5 openings at both ends. The lancing member 30 which is part of disposable 33
is capable of being retracted or deployed so that it can protrude beyond the end
of the main body 1 is positioned at one end. The arming tabs 37 protrude from
the sides of main body 1. The lancing member 30 is guarded by being
withdrawn into the tube 35 which is part of the disposable 33. The tube 35 acts
10 as the lancing guide and lancet guard The disposable 33 is attached to the
main body 1 so that it is positioned at the appropriate location to guide the
lancet and is held in place by the disposable clamp 3, The striker 39 is
projected so as to drive the lancet into the patient 41 by the spring 43 and the
arming plunger assembly 36. The arming plunger is locked in place by a cam
15 45 and trigger 47. A double stop return spring 49 is located and sized to return
the lancet 30 back into the tube 35.
The double stop return springs 49 provide a mechanism after activation
to pull the needle back out of the wound to permit blood 61 accumulation.
When the skin is pierced the secondary springs 49 retract the needle from the
20 wound and initiate the stimulation ring 25 oscillation system to force blood
flow to the wound. The cam 55 oscillates the oscillator ring 57 which transmits
the motion to stimulation ring 25. The stimulator ring can oscillate in the
preferred range of I to 5 mm. The frequency can vary from 20 to 200 cycles
per minute in the preferred embodiment. The oscillation of the stimulator ring
25 25 is driven by the motor 51. The battery 56 provides energy to run the motor
51 which oscillates the stimulator ring 25 to pump the blood 61 from the
surrounding capillaries in the skin into the wound. Each down stroke of the
stimulator ring 25 compresses the stimulator spring 53 which provides the return
motion for the stimulator ring 25. The disposable chemical strip 83 is then
30 lowered onto the blood bead using a secondary motion spring 74 that is released
by a secondary motion trigger 75, and suction of the blood initiated. The blood
-31 -
WO 97/42888
PCT7US97/08762
is absorbed by the disposable chemical strip 83. The strip is then removed and
read by the patient.
The stop and adjustment tabs 19 control the depth of penetration of the
lancet 30 so that the optimal depth of penetration is reached for a particular
5 sample site.
Figure 18 illustrates an integration of the minimally invasive sampling
device using a disposable piercing, stimulating and puncture depth adjustment
apparatus 92, The device can assume any of the configurations described by
this invention. This modification replaces items 19, 30, 72, 25, 3 on a typical
10 reusable sampling device such as Figure 11. The disposable unit can
incorporate a test strip, a sample container, an electrical sensing unit, or other
testing or sampling component.
Figure 19A shows the concept of a dual alternating stimulation ring
system. The secondary stimulation ring 120 alternates it's position 180 degrees
15 out of phase of stimulation ring 25. This creates a peristaltic pumping action on
the capillaries adjacent to the wound. This device can be used with any
embodiment to increase the blood flow. Link 121 connects the two rings with
body 1. The peristaltic pumping results in squeezing the body fluid to the
wound by massaging the fluid inward towards the wound.
20 Figure 19B shows the concept of concentric collapsing stimulation ring.
In this embodiment the inner ring 25 contacts the skin after the outer ring 120.
Spring 299 provides resistance and sequencing so that the outer ring 120
contacts the skin prior to inner ring 25. This squeezes the body fluid to the
wound by massaging the fluid inward towards the wound.
25 I" an alternate embodiment ring 25 can also function as the sample
collection tube after lancing needle 16 is retracted.
In another alternate embodiment compressed gas pulses can be applied in
the annular spaces between housing 1 and ring 120 and/or between ring 120 and
ring 25 to massage the skin and stimulate blood flow. Such action by
30 compressed gas pulses can be used instead of or in combination with the
movement of ring 120 or other stimulation members.
-32-
WO 97/42888
PCT/US97/08762
Figure 20A illustrates a bell shape capillary tube 150 which is used to
capture a sample of body fluid. The bell shape capillary is shaped to fit around
the drop and it is drawn up the tube until it reaches the bulb 151. This assist in
assuring that adequate sample 152 is drawn and the bulb 151 breaks the
5 capillary action. The sample 152 is dispensed by compressing the bulb 151.
The capillary can be heated to increase the draw of the capillary tube and the
speed of the sample collection.
Figure 20B and 20C show an alternative method where the sample 152
is wicked up the tube 150 and the tube is inverted so that the sample can by
10 transferred to a absorbent test pad 153.
Figure 20D shows a strait capillary 310 where the sample 152 is wicked
up the tube 310 and is transferred to the absorbent test pad 153 by capillary
action of the pad.
The tubes shown in 20A, 20B, 20C, and 20D can be modified with a
15 surfactant to increase the ability to wick up the bodily fluid.
Figure 21 illustrates a device where the oscillation ring 130 is fixtured to
disposable clamp 3 to oscillate the needle 33 to stimulate the wound and hold it
open so that it does not close around the wound. In addition a heated ring 135
can be used to increase the capillary volume to stimulate blood flow.
20 Figure 22A shows a multiple needle lancing device which is used to
cause multiple wounds to increase sample size. The multiple needles are of
sufficient size and length to minimize the pain sensation and still generate
adequate sample size.
Figure 22B shows a broader single lancet which is used to cause multiple
25 wounds to increase sample size.
Figure 22C and 22D shows a die cut sheet which has small multiple
barbs formed in it which is used to cause multiple wounds to increase sample
size. The multiple barbs are of sufficient size and length to minimize the pain
sensation and still generate adequate sample size.
30 The lancing device of Figures 22A through 22D can be used in the
sampling devices disclosed herein.
- 33 -
WO 97/42888
PCT/US97/08762
We Claim :
1. A device for obtaining a sample of body fluid through the skin
comprising:
a housing member suitable for use and adapted to contain a
5 needle for piercing the skin;
a spring member in the housing for urging the needle to protrude
from the end of the housing sufficient to penetrate the skin;
a plunger member for retracting the needle against the spring
tension and a trigger member to engage the plunger to hold the needle
10 retracted until released by the trigger;
a stop member to limit the depth of needle penetration of the skin
when released by the trigger;
a sample container communicating with the needle for receiving
the sample from the needle; and
15 a second spring for retracting the needle from the skin and a
suction cam and plunger activated upon the retraction of the needle for
drawing the sample of fluid which accumulates on the surface of the skin
into the sample container.
2. A device according to claim 1 comprising a skin stimulation
20 member for contacting and massaging the skin;
a skin stimulation member for contacting and massaging the skin;
an oscillation system for oscillating the skin stimulation member;
and
a spring and actuator member adapted for activating the
25 oscillation system upon retraction of the needle from the skin.
3. A device according to claim 2 comprising:
an actuator to deploy the stimulation member in the down
position before needle penetration of the skin for holding the skin taut
and for providing accurate depth control of needle penetration.
.34-
WO 97/42888
PCT/US97/08762
4. A device according to claims 1, 2 or 3 comprising:
an actuator system for cyclic movement of the needle in the
vertical or horizontal direction while the needle is inserted into the skin.
5. A device for obtaining a sample of body fluid through the skin
5 comprising:
a housing member adapted to contain a needle for piercing the
skin;
a drive means in the housing for urging the needle to protrude
from the end of the housing sufficient to penetrate the skin;
10 a stop member to limit the depth of needle penetration into the
y
skin by the device means;
a sample container communicating with the needle for receiving
the sample from the needle;
means for retracting the needle from the skin; and
15 means for drawing the sample of fluid which accumulates on the
surface of the skin into the sample container upon needle retraction.
6. A device according to claim 5 further comprising a skin
stimulation member for contacting and massaging the skin at the point of needle
pierce;
20 a skin stimulation member for contacting and massaging the skin;
an oscillation system for oscillating the skin stimulation member;
and
a spring and actuator member adapted for activating the
oscillation system upon retraction of the needle from the skin.
25 7. A device according to claim 6 further comprising a spring and
actuator member adapted for activating the oscillation system upon retraction of
the needle from the skin.
- 35 -
WO 97/42888
PCT/US97/08762
5
10
8. A device for obtaining a sample of body fluid through the skin
comprising:
a housing member suitable for hand held use and adapted to
contain a member or system for piercing the skin;
a sample collection tube positioned to collect a sample of fluid
emerging from the pierced skin; and
an actuator for causing the member or system to pierce the skin.
9. A device according to claim 8 wherein the system for piercing the
skin comprises laser system or a fluid under pressure directed to pierce the skin.
10. A device according to claim 8 wherein the member for piercing
the skin comprises a needle positioned adjacent the end of the tube and driving
member for urging the needle into the skin and a second member for retracting
the needle from the skin.
11. A device according to claim 10 wherein the tube is a
15 multichambered tube containing in one chamber a needle and adapted for
receiving the sample in a second chamber.
12. A device according to claims 8, 9, 10 or 1 1 comprising a pump
system for pulling the fluid sample into the tube.
13. A multichambered tube for use in a body fluid sampling device
20 for obtaining a sample of fluid through the skin comprising:
one chamber in the tube containing a needle adapted for piercing
the skin; and
a second chamber in the tube adapted for receiving a sample of
fluid from the pierced skin.
-36-
WO 97/42888
PCI7US97/08762
14. A device for collecting a sample of body fluid from a wound in
the skin comprising:
a housing member suitable for use containing a chamber for
collecting a sample of fluid emerging from the wound; and
5 a skin stimulation member movably positioned at the end of the
housing member for contacting a massaging the skin near the wound to
stimulate the flow of fluid to and out of the wound.
15. A device according to claim 14 wherein a stimulation member is
positioned between the chamber and the housing and is adapted to telescopically
10 extend from the housing to contact the skin and pump the body fluid to the
wound.
16. A device according to claim 15 wherein the stimulation member
is adapted to increase the opening of the wound and enhance fluid flow from the
wound.
15 17. A device according to claim 15 wherein the stimulation member
is adapted to stroke the skin toward the wound to enhance fluid flow from the
wound.
18. A device according to claim 2, 6 or 14 wherein the stimulation
member comprises a polygon, square, circular or annular shape, a paddle or
20 squeegee member, a system for employing a fluid under pressure to contact and
stimulate the skin, or a fluid contained in a flexible membrane for contacting
and stimulating the skin.
19. A needle for piercing the skin comprising a hollow tube having a
pointed spade protrusion extending substantially longitudinally from a portion of
25 one side of the end of the tube.
- 37 -
WO 97/42888
PCT7US97/08762
20. A needle according to claim 19 wherein the spade portion is
angled toward the center line of the tube.
21. A needle having an angled or beveled tip for piercing the skin
comprising a hollow tube wherein the longitudinal passageway in the tube is
5 eccentrically located in the tube.
22. A device for use in a body fluid sampling device for obtaining a
sample through the skin comprising:
a standoff member adapted for contacting the skin;
a sample collection tube positioned in the standoff member for
10 receiving the fluid sample;
a lancet member movably positioned in the standoff member
adjacent to the tube for piercing the skin; and
electrodes positioned in the standoff member adapted for
connection to a sensor to sense the presence of fluid within the standoff
15 member.
23. The device of claim 22 further comprising electrodes positioned
in the collection tube for connection to a sensor to sense the presence and
amount of fluid within the collection tube.
24. A device according to claims 1, 5, 8, 13, 14, 20 or 22 further
20 comprising:
an integral test unit for testing the sample.
24. A device according to claim 23 wherein the test unit comprises a
colorimetric test unit or an electrochemical test unit.
25. A device of claims l t 5, 8, 13, 14, or 22 adapted to receive a test
25 device unit which absorbs the sample from the wound site.
-38-
WO 97/42888
PCT/US97/08762
26. A body fluid collection device comprising a capillary tube flared
on one end for contacting the skin and having a suction member positioned on
the opposite end.
27. A device according to claim 26 further comprising a test strip on
5 which the fluid sample is deposited from the capillary tube.
28. A device for use in a body fluid sampling device for obtaining a
sample through the skin comprising:
an elongated holder member having a plurality of passageways
extending longitudinally through the member; and /
10 lancet members positioned in said passageways and adapted for
creating a plurality of wounds in the skin when contacted with the skin.
29. A device for use in a body fluid sampling device for obtaining a
sample through the skin comprising: .
a plate member having a plurality of sharp protrusion extending
15 from one side of the plate member adapted for creating a plurality of
wounds in the skin when contacted with the skin. ,
30. A device according to claims 2, 6 or 14 wherein the stimulation
member or system comprises a flat spiral spring, ultrasonic action, piezoelectric
action, heating, friction or vibration.
20 ■ . 31. A lancing device for piercing the skin comprising multiple
lancing members formed from needles or barbs.
32. A method of collecting a sample of body fluid which includes
piercing the skin;
-39-
WO 97/42888
PCT/US97/08762
mechanically stimulating the wound created by piercing the skin;
collecting the sample which results from the stimulating; and
dispensing the sample.
33. A device according to claim 4 wherein the activator system
5 comprises ultrasonic, piezoelectric, mechanical or electrical action.
34. A device according to claims 1, 5, 8, 13, 14 or 22 further
comprising a system for injecting a material into the skin.
35. A device according to claims 1, 5, 13, 14 or 22 further
y .
comprising suction means for pulling a sample into the needle, tube or chamber.
10 36. A device according to claims 1, 5, 8, 13, 25. 22, 28, 29 or 31
wherein the needle, the system for piercing the skin or lancet member is adapted
to pierce the skin at an angle less than 90°.
37. A device according to claim 36 adapted to stimulate the skin prior
to or during the peircing the skin.
15 38. A device according to claims 1, 5, 8, 13, 14, 22, 28, 29 or 31
wherein the portion of the device which pierces the skin and the portion of the
device which collects or contains the sample are disposable units.
39. A device according to claims 1 , 5, 8, 13, 14, 22, 28, 29 or 3 1
wherein the portion of the device which pierces the skin is adapted to oscillate
20 while inserted into the skin which oscillation is by vertical, horizontal, rotation
or cyclic movement
40, A device according to claims 1, 5, 8, 13, 14 or 22 further
comprising a system for imposing an electric potential across the skin from a
-40-
WO 97/42888
PCT/US97/08762
point distant from the wound in the skin to a point near or in the wound in the
skin.
41. A device according to claims 1, 5, 8, 13, 14 or 22 comprising a
system to measure the volume of the sample collected.
5 42. A device according to claim 41 wherein the measuring system is
adapted to stop the sample collection at a predetermined volume of sample.
43. A device according to claims I, 5, 8, 13, 14, 22 or 26 wherein the
sample container or sample collection tube comprises a material having an 7
affinity for the sample fluid sufficiently high to collect the fluid sample from the
10 surface of the skin but sufficiently low to allow the fluid sample to wick from
the container or tube when placed in contact with a test strip or device having
an affinity for the fluid sample higher than that of the container or tube.
44. A method of collecting a sample of body fluid comprising:
piercing the skin with a hypodermic needle;
15 withdrawing the needle from the skin;
massaging an area adjacent the wound; and
collecting a sample of fluid from the surface of the skin into the
hypodermic needle.
45. A method for collection a sample of a body fluid comprising:
20 mechanically massaging a skin area;
piercing the skin to create a wound;
mechanically massaging a skin area adjacent the wound; and
collecting a fluid sample from the wound or the surface of the skin.
46. A method according to claim 45 comprising inserting a device to
25 pierce the skin and oscillating the device in the wound.
-41 -
PCT7US97/08762
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
2/23
SUBSTITUTE SHEET (RULE 26)
WO 97/42888 PCT/US97/08762
3/23
FIG. 3
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT7US97/08762
4/23
siiwniidvo
V v
NMS
SUBSTITUTE SHEET (RULE 26)
5/23
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
FIG. 4C
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCIYUS97/08762
8/23
FIG. 4F
FIG. 4G
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
9/23
FIG. 41
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
10/23
FIG. 5 A FIG. 5B
FIG. 6B
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
11/23
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
12/23
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCTAJS97/08762
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
14/23
FIG. 11
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
16/23
FIG. 13 FIG. 14
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
17/23
FIG. 15 FIG. 16
SUBSTITUTE SHEET (RULE 26)
>
WO 97/42888
PCT/US97/08762
SUBSTITUTE SHEET (RULE 26)
19/23
FIG. 19 A
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
20/23
SUBSTITUTE SHEET (RULE 26)
WO 97/42388
PCTAJS97/08762
FIG. 20 A
FIG. 20B
153
310
153
FIG. 20C
FIG. 20D
SUBSTITUTE SHEET (RULE 26)
WO 97/42888
PCT/US97/08762
22/23
FIG. 21
PCT/US97/08762
23/23
SUBSTITUTE SHEET (RULE 26)
INTERNATIONAL SEARCH REPORT
International application No.
PCT/US97/08762
A. CLASSIFICATION OF SUBJECT MATTER
IPC(6) :A6IB 17/32
USCL ;606/181
According to International Patent CUwifictUoo (IPC) or to both
national classification and IPC
B- FIELDS SEARCHED
Minimum documentation searched (classification system followed by classification lyraboU)
U.S. : 606/181
Documentation searched other than minimum documentation to the extent that such documents are included m the fields
searched
Electronic data base consulted during the international search (name of data base and, where practicable, .earch term, used)
C DOCUMENTS CONSIDERED TO BE RELEVANT
Category*
Citation of document, with indication, where appropriate, of the relevant passages
Relevant to claim No.
US 5,368.047 A (SUZUKI etal.) 29 November 1994, entire
document.
US 5,165,418 A (TANKOVICH) 24 November 1992, entire
document.
US 4,637,403 A (GARCIA et al.) 20 January 1987, entire
document.
US 4,994,073 A (GREEN) 19 February 1991, entire
document.
US 4,627,445 A (GARCIA et al.) 09 December 1986, entire
document.
US 4,360.016 A (SARRINE) 23 November 1982, entire
document.
1, 5, 8, 10, 12,
19-21, 41, 42
8, 9
8, 23-25
28, 29, 31
14, 30, 32, 38,
41. 42.
10,11,13
*j Further docuroenti ut H»trd in the contimatioa of Box C. Q Sec patent
family annex.
tofcaofa
fifiaf •■■> or priority
Bfft*.
torfior 49C)mI|mUM m or after tfco
■ pfi
i of
•X"
. ... — w— w www rm iioooo> M lo»oJk> » ¥ot¥o — ■ n ^iiia
Hnj"lr o l!h!»VZ tlhT^ ^^T ^iiZ ^^dooas^fatoamoloma
^cMmmlaswfU) *Y* I * **** wh »a « ctofcnoa i n i [ ■ «— et
log— m mfcwtog to m oral <SkW ml nfcil ¥ ■ or — — " ?! i^"^?* JT*"? *V* """■ IB<
beat obvfea to a pom «JM k to art
■J prior tot
"Tr| in tosh— ..■
Date of the actual completion of the international search
17 AUGUST 1997
Name and mailing address of the ISA/US
T False* and T
Box per
Washington, D.C. 20231
Facsimile No. (703) 305-3230
Form PCTY1SA/210 (second sbeetXJuly 1992)*
Date of mailing of the international search report
1 2 SEP 1997
Authorized officer
TWA T. D. PRAM
Telephone No. (703) 308-0824
INTERNATIONAL SEARCH REPORT
C (Continuation). DOCUMENTS CONSIDERED TO BE RELEVANT
International application No.
PCT/US97/08762
Category'
Citation of document, with indication, where appropriate, of the relevant paiaagca
Relevant to claim No.
US 4,687,000 A (EISENHARDT et al.) 18 August 1987, entire
document.
8, 36
Form PCT/IS A/210 (continuation of second ghectXJuly 1992)*